drugset / Trial / NCT02679781

Nasal Versus Oral Midazolam Sedation in Routine Pediatric Dental Care

NCT02679781 ↗

Completed 70 enrolled Hadassah Medical Organization
RandomizedParallel-groupSingle-blindTreatment

Summary

The general objective of the study is to compare the efficacy of administering midazolam orally as syrup versus nasally with nasal atomizer. The specific objectives are to measure: 1) acceptability of the medication, 2) effect on behavior, 3) time of onset, 4) maximum working time.

Timeline

Start
2017-03-28
Primary completion
2020-12-15
Completion
2020-12-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Midazolam Small molecule 0.2 mg/kg Oral
Comparator Midazolam Small molecule 0.5 mg/kg Oral

Indications

No indication recorded.